ISSCR News
![ISSCR Announces Endorsement for California Initiative to Fund Stem Cell Research ](https://images.squarespace-cdn.com/content/v1/611faaa8fee682525ee16489/1658427813836-AGZX5C96SYT14JGROIX0/unsplash-image-PGRlGx_6Ehk.jpg)
ISSCR Announces Endorsement for California Initiative to Fund Stem Cell Research
The ISSCR announces its endorsement for the California initiative to invest $5.5 billion in stem cell research to continue the research and development of new therapies for life-threatening and devastating diseases. The new initiative will build on the historic $3 billion investment made by California in 2004, which created the California Institute for Regenerative Medicine (CIRM) and established the state as a leader in the field. While stem cell research holds enormous potential, more research is needed to develop and test safe and effective stem cell-based treatments…
![ISSCR Comments on Need to Improve ClinicalTrials.gov Database to Prevent Abuse](https://images.squarespace-cdn.com/content/v1/611faaa8fee682525ee16489/1658428136114-7JX4S7Q75MFZUNWW53XS/unsplash-image-gQI8BOaL69o.jpg)
ISSCR Comments on Need to Improve ClinicalTrials.gov Database to Prevent Abuse
The ISSCR urges NIH to improve the ClinicalTrials.gov to prevent the database from being abused by clinics marketing unproven stem cell interventions. The comments are in response to a request for information from the National Library of Medicine (ClinicalTrials.gov Modernization, Notice Number: NOT-LM-20-003).
![ISSCR Urges UK Agency to Increase Enforcement for the Marketing of Unproven Products](https://images.squarespace-cdn.com/content/v1/611faaa8fee682525ee16489/1658427957164-79HNDCW5F7K7KY3FPN44/unsplash-image-cYUMaCqMYvI.jpg)
ISSCR Urges UK Agency to Increase Enforcement for the Marketing of Unproven Products
The ISSCR writes to urge the Medicines and Healthcare Products Regulatory Agency to increase enforcement activities to prevent the marketing and commercialization of stem cell-related products that are unproven and do not conform to United Kingdom (UK) and European Union (EU) Advanced Therapy Medicinal Product (ATMP) regulations.
![Member Spotlight: Kirstin Matthews, PhD](https://images.squarespace-cdn.com/content/v1/611faaa8fee682525ee16489/7b302b17-ad35-4811-a0c3-6148ff1c35b2/Kirstin_Matthews_500x500.jpg)
Member Spotlight: Kirstin Matthews, PhD
“Science policy is a collaborative endeavor. You need a strong understanding of the current research to make thoughtful and actionable recommendations for policy”.
![Member Spotlight: Rana Dajani, PhD](https://images.squarespace-cdn.com/content/v1/611faaa8fee682525ee16489/b0a2802a-e2c8-4fbb-b1b0-b0861994aa39/Rana+Dajani_500x500.png)
Member Spotlight: Rana Dajani, PhD
“The current focus of my work is the epigenetics of trauma and whether trauma can be inherited across generations. Exploring new hypotheses to explain nature around us is thrilling and exhilarating. Science is the only frontier that never ends and is continuously evolving. There is no limit to human curiosity”.
![](https://images.squarespace-cdn.com/content/v1/611faaa8fee682525ee16489/1e898b25-2b77-4f85-aea4-e33ef01a920e/mouse+neural+stem+cell.jpg)
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .